AKTX

Akari Therapeutics
AKTX

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $1.89M invested in Akari Therapeutics in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

13% less capital invested

Capital invested by funds: $2.16M → $1.89M (-$271K)

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$109K
2
+$49.2K
3
+$20K

Top Sellers

1
-$17K
2
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$910K
2
$543K
3
$157K
4
$120K
5
$56K
6
$36K
7
$25K
8
$20K
9
$14K
10
$7K
11
$4K
12
–